|
US1268002A
(en)
|
1917-09-12 |
1918-05-28 |
William M Goodwin |
Measuring instrument.
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
GB9604926D0
(en)
|
1996-03-08 |
1996-05-08 |
Sandoz Ltd |
Organic compounds
|
|
MXPA04012393A
(es)
|
2002-06-12 |
2005-06-17 |
Chemocentryx |
Derivados de piperazina 1-aril-4-substituidos para utilizar como antagonistas ccr1 para tratamiento de inflamacion y desordenes inmunes.
|
|
AU2003298661B2
(en)
|
2002-11-18 |
2007-05-10 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
CA2566387A1
(en)
|
2004-05-12 |
2005-12-01 |
Chemocentryx, Inc. |
Aryl sulfonamides as chemokine receptor ccr9 antagonists
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
WO2006076644A2
(en)
|
2005-01-14 |
2006-07-20 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and ccr2
|
|
ZA200800309B
(en)
|
2005-06-22 |
2009-10-28 |
Chemocentryx Inc |
Azaindazole compounds and methods of use
|
|
US7790726B2
(en)
|
2005-08-16 |
2010-09-07 |
Chemocentryx, Inc. |
Monocyclic and bicyclic compounds and methods of use
|
|
WO2007044885A2
(en)
|
2005-10-11 |
2007-04-19 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
DE602006018057D1
(de)
|
2005-11-10 |
2010-12-16 |
Chemocentryx Inc |
Substituierte chinolone und verwendungsverfahren
|
|
US7807704B2
(en)
|
2006-03-30 |
2010-10-05 |
Chemocentryx, Inc. |
Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
|
|
WO2007115232A2
(en)
|
2006-03-30 |
2007-10-11 |
Chemocentryx, Inc. |
Cxcr4 modulators
|
|
EP2402317B1
(en)
|
2006-03-31 |
2013-07-03 |
Novartis AG |
DGAT inhibitor
|
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
|
ATE496905T1
(de)
|
2006-07-14 |
2011-02-15 |
Chemocentryx Inc |
Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose
|
|
US20100234364A1
(en)
|
2006-07-14 |
2010-09-16 |
Arindrajit Basak |
Ccr2 inhibitors and methods of use thereof
|
|
AU2007275873B2
(en)
|
2006-07-14 |
2012-06-14 |
Chemocentryx, Inc. |
Triazolyl phenyl benzenesulfonamides
|
|
NZ581405A
(en)
|
2007-05-22 |
2011-06-30 |
Chemocentryx Inc |
3-(Imidazolyl)-pyrazolo[3,4-b]pyridines and their use in treating CCR1-mediated disorders
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
CN101820881B
(zh)
|
2007-07-12 |
2013-05-01 |
坎莫森特里克斯公司 |
作为ccr2调节剂用于治疗炎症的稠合杂芳基吡啶基和苯基苯磺酰胺
|
|
MX2011002636A
(es)
|
2008-09-11 |
2011-04-05 |
Chemocentryx Inc |
4-amino-3-(imidazoil)-pirazolo[3,4-d]pirimidinas.
|
|
WO2010051561A1
(en)
|
2008-11-03 |
2010-05-06 |
Chemocentryx, Inc. |
Compounds for the treatment of osteoporosis and cancers
|
|
CN102271681B
(zh)
|
2008-11-04 |
2014-11-12 |
凯莫森特里克斯股份有限公司 |
Cxcr7调节剂
|
|
SMT202200074T1
(it)
|
2008-12-22 |
2022-03-21 |
Chemocentryx Inc |
Antagonisti di c5ar
|
|
WO2011035332A1
(en)
|
2009-09-21 |
2011-03-24 |
Chemocentryx, Inc. |
Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators
|
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
|
HRP20171176T1
(hr)
|
2010-06-24 |
2017-10-06 |
Chemocentryx, Inc. |
C5ar antagonisti
|
|
UY34451A
(es)
|
2011-11-14 |
2013-05-31 |
Cephalon Inc |
Derivados de uracilo como inhibidores de la quinasa axl y c-met
|
|
ES2648340T3
(es)
|
2011-12-01 |
2018-01-02 |
Chemocentryx, Inc. |
Benzoimidazoles y benzopirazoles substituidos como antagonistas de CCR(4)
|
|
JP6141864B2
(ja)
|
2011-12-01 |
2017-06-07 |
ケモセントリックス，インコーポレイティド |
Ｃｃｒ（４）アンタゴニストとしての置換アニリン
|
|
WO2013085802A1
(en)
|
2011-12-06 |
2013-06-13 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
RU2627268C2
(ru)
|
2012-02-29 |
2017-08-04 |
Хемоцентрикс, Инк. |
Аза-арил-1Н-пиразол-1-ил-сульфонамиды
|
|
ES2681593T3
(es)
|
2012-11-29 |
2018-09-14 |
Chemocentryx, Inc. |
Antagonistas de CXCR7
|
|
AU2013355054B2
(en)
|
2012-12-07 |
2017-08-24 |
Chemocentryx, Inc. |
Diazole lactams
|
|
US9169248B2
(en)
|
2012-12-21 |
2015-10-27 |
Chemocentryx, Inc. |
Diazole amides
|
|
ES2642074T3
(es)
|
2013-09-04 |
2017-11-15 |
Bristol-Myers Squibb Company |
Compuestos útiles como inmunomoduladores
|
|
EP3385257A1
(en)
|
2013-09-06 |
2018-10-10 |
Aurigene Discovery Technologies Limited |
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
|
|
CN105814028B
(zh)
|
2013-09-06 |
2018-02-16 |
奥瑞基尼探索技术有限公司 |
作为免疫调节剂的1，2，4‑*二唑衍生物
|
|
EA029826B1
(ru)
|
2013-12-02 |
2018-05-31 |
Кемосентрикс, Инк. |
Соединения против ccr6
|
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
JP6767096B2
(ja)
|
2014-12-11 |
2020-10-14 |
リティックス バイオファーマ エイエス |
免疫チェックポイント阻害剤の組み合わせ
|
|
JP6786520B2
(ja)
|
2015-04-21 |
2020-11-18 |
ジーティーエックス・インコーポレイテッド |
選択的アンドロゲン受容体分解剤（ｓａｒｄ）リガンド及びその使用方法
|
|
US20180118718A1
(en)
|
2015-05-13 |
2018-05-03 |
Selvita S.A. |
Substituted Quinoxaline Derivatives
|
|
PT3297438T
(pt)
|
2015-05-21 |
2022-01-25 |
Chemocentryx Inc |
Moduladores de ccr2
|
|
NL1041468B1
(en)
|
2015-09-08 |
2017-03-22 |
Bosch Gmbh Robert |
Metal ring component of a drive belt for a continuously variable transmisson.
|
|
EP3156405A1
(en)
*
|
2015-10-13 |
2017-04-19 |
Boehringer Ingelheim International GmbH |
Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxamide
|
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
MD3377488T2
(ro)
|
2015-11-19 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
MA44075A
(fr)
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
|
MY199705A
(en)
|
2015-12-22 |
2023-11-20 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
|
SG11201806153QA
(en)
|
2016-01-20 |
2018-08-30 |
Chemocentryx Inc |
2-oxindole compounds
|
|
WO2017176620A2
(en)
|
2016-04-04 |
2017-10-12 |
Chemocentryx, Inc. |
SOLUBLE C5aR ANTAGONISTS
|
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
RU2735541C2
(ru)
|
2016-05-23 |
2020-11-03 |
Инститьют Оф Материя Медика, Чайниз Экедеми Оф Медикал Сайенсез |
Простое эфирное производное никотинилового спирта, получение и фармацевтическая композиция и применения
|
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
KR102685249B1
(ko)
|
2016-06-20 |
2024-07-17 |
인사이트 코포레이션 |
면역조절제로서의 복소환식 화합물
|
|
KR102401963B1
(ko)
*
|
2016-06-27 |
2022-05-25 |
케모센트릭스, 인크. |
면역조절제 화합물
|
|
EP3483142B1
(en)
|
2016-07-05 |
2025-10-15 |
Beijing Maxinovel Pharmaceuticals Co., Ltd. |
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
|
|
KR102491992B1
(ko)
|
2016-07-08 |
2023-01-25 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제로서 유용한 1,3-디히드록시-페닐 유도체
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
WO2018045142A1
(en)
|
2016-09-02 |
2018-03-08 |
Polaris Pharmaceuticals, Inc. |
Immune checkpoint inhibitors, compositions and methods thereof
|
|
JP7106572B2
(ja)
|
2016-12-20 |
2022-07-26 |
ブリストル－マイヤーズ スクイブ カンパニー |
免疫調節剤として有用な化合物
|
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
EP3558989B1
(en)
|
2016-12-22 |
2021-04-14 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
PE20191532A1
(es)
*
|
2016-12-22 |
2019-10-23 |
Incyte Corp |
Compuestos heterociclicos como inmunomoduladores
|
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018119224A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
CA3047991A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
CN106674136B
(zh)
|
2016-12-23 |
2019-07-02 |
中国医科大学 |
嘧啶类抗肿瘤化合物及其制备方法
|
|
EP3564237A4
(en)
|
2016-12-29 |
2020-06-10 |
Shenzhen Chipscreen Biosciences Co., Ltd. |
UREA COMPOUND AND PRODUCTION METHOD AND USE THEREOF
|
|
CN108395443B
(zh)
|
2017-02-04 |
2021-05-04 |
广州丹康医药生物有限公司 |
抑制程序性死亡受体配体1的环状化合物及其用途
|
|
JP7150745B2
(ja)
|
2017-03-27 |
2022-10-11 |
ブリストル－マイヤーズ スクイブ カンパニー |
免疫調節剤としての置換イソキノリン誘導体
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
TW201841896A
(zh)
|
2017-04-26 |
2018-12-01 |
大陸商南京聖和藥業股份有限公司 |
作為pd—l1抑制劑的雜環類化合物
|
|
CN108863963B
(zh)
|
2017-05-08 |
2022-05-27 |
南京圣和药物研发有限公司 |
作为pd-l1抑制剂的杂环类化合物
|
|
NZ759297A
(en)
|
2017-05-31 |
2026-03-27 |
Chemocentryx Inc |
6-5 fused rings as c5a inhibitors
|
|
KR102586710B1
(ko)
|
2017-05-31 |
2023-10-10 |
케모센트릭스, 인크. |
C5a 억제제로서의 5-5 융합 고리
|
|
MA49701A
(fr)
|
2017-07-28 |
2020-06-03 |
Chemocentryx Inc |
Composés immunomodulateurs
|
|
CN111225665B
(zh)
|
2017-08-08 |
2023-12-08 |
凯莫森特里克斯股份有限公司 |
大环免疫调节剂
|
|
CN109400522B
(zh)
|
2017-08-18 |
2023-04-28 |
上海轶诺药业有限公司 |
一种具有pd-l1抑制活性的化合物、其制备方法及用途
|
|
US20190275015A1
(en)
|
2017-09-25 |
2019-09-12 |
Chemocentryx, Inc. |
Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor
|
|
MA50665A
(fr)
|
2017-09-25 |
2020-08-05 |
Chemocentryx Inc |
Polythérapie utilisant un antagoniste du récepteur 2 de la chimiokine (ccr2) et un inhibiteur pd-1/pd-l1
|
|
EP3692053A1
(en)
|
2017-10-03 |
2020-08-12 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
CN109665968B
(zh)
|
2017-10-16 |
2022-02-22 |
四川科伦博泰生物医药股份有限公司 |
并环化合物及其制备方法和用途
|
|
CN109678796B
(zh)
|
2017-10-19 |
2023-01-10 |
上海长森药业有限公司 |
Pd-1/pd-l1小分子抑制剂及其制备方法和用途
|
|
CN109721527B
(zh)
|
2017-10-27 |
2024-03-12 |
广州丹康医药生物有限公司 |
一种新型抗pd-l1化合物、其应用及含其的组合物
|
|
BR112020008851A2
(pt)
|
2017-11-06 |
2020-10-20 |
Jubilant Prodel LLC |
composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
|
|
WO2019120297A1
(zh)
|
2017-12-22 |
2019-06-27 |
上海海雁医药科技有限公司 |
免疫调节剂及其制法与医药上的用途
|
|
EP3733659B1
(en)
|
2017-12-29 |
2023-12-20 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd. |
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
|
|
JP7214752B2
(ja)
|
2018-01-23 |
2023-01-30 |
ブリストル－マイヤーズ スクイブ カンパニー |
免疫調節剤として有用な２，８－ジアシル－２，８－ジアザスピロ［５．５］ウンデカン化合物
|
|
ES3035608T3
(en)
|
2018-02-05 |
2025-09-05 |
Abbisko Therapeutics Co Ltd |
Biaryl derivatives and their pharmaceutical application for the treatment of pd-1/pd-l1 signal pathway-mediated diseases
|
|
KR102708681B1
(ko)
|
2018-02-13 |
2024-09-26 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
US10568874B2
(en)
|
2018-02-22 |
2020-02-25 |
Chemocentryx, Inc. |
Indane-amines as PD-L1 antagonists
|
|
WO2019169123A1
(en)
|
2018-03-01 |
2019-09-06 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
WO2019174533A1
(zh)
|
2018-03-13 |
2019-09-19 |
广东东阳光药业有限公司 |
Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
|
|
SG11202008950PA
(en)
|
2018-03-13 |
2020-10-29 |
Jubilant Prodel LLC |
Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
|
|
RS64055B1
(sr)
*
|
2018-03-30 |
2023-04-28 |
Incyte Corp |
Heterociklična jedinjenja kao imunomodulatori
|
|
CN111936475B
(zh)
|
2018-04-03 |
2024-05-10 |
贝达药业股份有限公司 |
免疫调节剂及其组合物和制备方法
|
|
EP4600247A3
(en)
|
2018-04-19 |
2025-11-19 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
MD3790877T2
(ro)
|
2018-05-11 |
2023-08-31 |
Incyte Corp |
Derivați de tetrahidro-imidazo[4,5-c]piridină în calitate de imunomodulatori PD-L1
|
|
WO2020011209A1
(zh)
|
2018-07-11 |
2020-01-16 |
上海和誉生物医药科技有限公司 |
免疫抑制剂及其制备方法和在药学上的应用
|
|
CN112384500B
(zh)
|
2018-07-12 |
2024-05-14 |
贝达药业股份有限公司 |
免疫调节剂及其组合物和制备方法
|
|
UA126421C2
(uk)
|
2018-07-13 |
2022-09-28 |
Гіліад Сайєнсіз, Інк. |
Інгібітори pd-1/pd-l1
|
|
US20210269440A1
(en)
|
2018-07-19 |
2021-09-02 |
Betta Pharmaceuticals Co., Ltd |
Immunomodulators, compositions and methods thereof
|
|
CN112424194B
(zh)
|
2018-07-19 |
2024-02-06 |
贝达药业股份有限公司 |
免疫调节剂及其组合物和制备方法
|
|
US20210347785A1
(en)
*
|
2018-08-01 |
2021-11-11 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
Preparation and application of aromatic compound having immunoregulatory function
|
|
MA53506A
(fr)
|
2018-08-29 |
2021-07-07 |
Chemocentryx Inc |
Méthodes de traitement du cancer avec des inhibiteurs de pd-l1 à petites molécules
|
|
CN109336857A
(zh)
|
2018-11-13 |
2019-02-15 |
南方医科大学 |
一种含取代联苯的黄酮及其应用
|
|
CN109438263A
(zh)
|
2018-11-28 |
2019-03-08 |
南方医科大学 |
一种含取代联苯的萘及其应用
|
|
CN109503546A
(zh)
|
2019-01-10 |
2019-03-22 |
南方医科大学 |
一种间苯二酚二苯甲醚及其应用
|
|
BR112021015131A2
(pt)
*
|
2019-01-31 |
2021-09-28 |
Betta Pharmaceuticals Co., Ltd |
Imunomoduladores, composições e métodos dos mesmos
|
|
CN109776377B
(zh)
|
2019-02-01 |
2021-08-24 |
沈阳药科大学 |
吲哚啉类化合物及其制备方法和应用
|
|
US20200297708A1
(en)
|
2019-03-19 |
2020-09-24 |
Chemocentryx, Inc. |
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
|
|
CN109776445B
(zh)
|
2019-03-28 |
2022-12-06 |
中国药科大学 |
苯并噁二唑类化合物及其制备方法和医药用途
|
|
US11266643B2
(en)
|
2019-05-15 |
2022-03-08 |
Chemocentryx, Inc. |
Triaryl compounds for treatment of PD-L1 diseases
|
|
CN110200959A
(zh)
|
2019-05-30 |
2019-09-06 |
天津科技大学 |
一种黄酮类化合物的应用
|
|
CN110128415B
(zh)
|
2019-05-31 |
2022-03-25 |
沈阳药科大学 |
用作免疫调节剂的吲哚啉类化合物及其制备方法
|
|
EP3986392A4
(en)
|
2019-06-20 |
2023-07-12 |
ChemoCentryx, Inc. |
COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES
|
|
US11872217B2
(en)
|
2019-07-10 |
2024-01-16 |
Chemocentryx, Inc. |
Indanes as PD-L1 inhibitors
|
|
US11713307B2
(en)
|
2019-10-16 |
2023-08-01 |
Chemocentryx, Inc. |
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
|
|
CR20220216A
(es)
|
2019-10-16 |
2023-01-09 |
Chemocentryx Inc |
Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1
|
|
AU2020366435A1
(en)
|
2019-10-16 |
2022-04-21 |
Morphic Therapeutic, Inc. |
Inhibiting human integrin α4β7
|
|
MX2022016554A
(es)
|
2020-06-23 |
2023-04-10 |
Chemocentryx Inc |
Métodos de tratamiento del cáncer mediante derivados heteroaril-bifenil-amida.
|